Author: Brito, Sérgio; Ferreira, Nuno; Mateus, Sofia; Bernardo, Manuela; Pinto, Beatriz; Lourenço, Ana; Grenho, Fátima
Title: A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination Cord-id: jecarlap Document date: 2021_5_15
ID: jecarlap
Snippet: Autoimmune hemolytic anemia (AIHA) is a condition characterized by the increased destruction of red blood cells (RBCs) mediated by anti-erythrocyte autoantibodies with or without complement activation. Its clinical presentation is heterogeneous, ranging from asymptomatic to severe forms with fatal outcomes, and it can be either idiopathic or secondary to a coexisting disorder. In this report, we present a case of a patient who suffered from acute and severe AIHA after receiving the second dose o
Document: Autoimmune hemolytic anemia (AIHA) is a condition characterized by the increased destruction of red blood cells (RBCs) mediated by anti-erythrocyte autoantibodies with or without complement activation. Its clinical presentation is heterogeneous, ranging from asymptomatic to severe forms with fatal outcomes, and it can be either idiopathic or secondary to a coexisting disorder. In this report, we present a case of a patient who suffered from acute and severe AIHA after receiving the second dose of the coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccine.
Search related documents:
Co phrase search for related documents- activity relationship and acute infection: 1
- acute infection and local regulation: 1, 2
- acute infection and lymphoid spleen: 1, 2, 3
- acute infection and lymphoproliferative disorder: 1
- acute kidney injury and admission hour: 1
Co phrase search for related documents, hyperlinks ordered by date